ClinicalTrials.Veeva

Menu

Magnesium Sulfate vs Placebo for Placental Abruption

Stanford University logo

Stanford University

Status

Completed

Conditions

Abruptio Placentae

Treatments

Other: Normal Saline
Drug: Magnesium Sulfate

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

To evaluate the safety and efficacy of magnesium sulfate for preterm suspected abruption.

Full description

We hope to learn if there is a difference in the efficacy of intravenous magnesium sulfate versus intravenous saline infusion in the resolution of vaginal bleeding and contractions in patients with a suspected placental abruption.

Enrollment

30 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • vaginal bleeding and contractions consistent with suspected placental abruption between 24 and 34 weeks gestation.

Exclusion criteria

  • preterm labor, severe bleeding necessitating immediate delivery, maternal coagulopathy, fetal distress

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Double Blind

30 participants in 2 patient groups, including a placebo group

Magnesium Sulfate
Active Comparator group
Description:
Magnesium Sulfate 4 gram bolus, followed by 2 grams per hour
Treatment:
Drug: Magnesium Sulfate
Normal Saline
Placebo Comparator group
Description:
Normal Saline 4 gram bolus, followed by 2 grams per hour
Treatment:
Other: Normal Saline

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems